Cite
MLA Citation
Vanita R. Aroda et al.. “Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials.” Diabetes, obesity & metabolism, vol. 22, no. 3, 2020, pp. 303–314. http://access.bl.uk/ark:/81055/vdc_100101550362.0x000022